EyePoint Pharmaceuticals vs Verdiva Bio
EyePoint Pharmaceuticals vs Verdiva Bio, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EyePoint Pharmaceuticals is on 36/100 and Verdiva Bio on 54/100.
Where each one leads
EyePoint Pharmaceuticals
- agent readiness: 50/100 against 21/100
- domain rating: 43/100 against 23/100
- funding raised: $436M against $170M
Verdiva Bio
- our overall score: 54/100 against 36/100
At a glance
| Measure | EyePoint Pharmaceuticals | Verdiva Bio |
|---|---|---|
| What it is | Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases. | Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases. |
| Category | Biotechnology, Biopharmaceuticals, Specialty Pharmaceuticals, Ophthalmology | Biotechnology, Pharmaceuticals, HealthTech, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 1987 | 2021 |
| Headquarters | Watertown, United States | San Diego, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | EyePoint Pharmaceuticals | Verdiva Bio |
|---|---|---|
| Employees | Not published | 74 |
| Total funding | $436M | $170M |
| Latest round | Public Offering | Series B |
| LinkedIn followers | Not published | 6,379 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EyePoint Pharmaceuticals | Verdiva Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 36/100 | 54/100 |
| Traction | 40/100 | 59/100 |
| Team | 30/100 | Not published |
| Community | Not published | 8/100 |
| Search visibility | 13/100 | 34/100 |
| Quality | 40/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 43/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EyePoint Pharmaceuticals | Verdiva Bio |
|---|---|---|
| Hosting | Google Cloud | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
EyePoint Pharmaceuticals vs Verdiva Bio: common questions
Which is better, EyePoint Pharmaceuticals or Verdiva Bio?
On our 0-100 score Verdiva Bio rates higher (54/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do EyePoint Pharmaceuticals and Verdiva Bio compare on the numbers?
EyePoint Pharmaceuticals leads on agent readiness (50/100 against 21/100), domain rating (43/100 against 23/100), funding raised ($436M against $170M). Verdiva Bio leads on our overall score (54/100 against 36/100).
Read the full EyePoint Pharmaceuticals review and pricing or the Verdiva Bio review and pricing. You can also browse other EyePoint Pharmaceuticals alternatives we track.